vs
IRONWOOD PHARMACEUTICALS INC(IRWD)与Ponce Financial Group, Inc.(PDLB)财务数据对比。点击上方公司名可切换其他公司
IRONWOOD PHARMACEUTICALS INC的季度营收约是Ponce Financial Group, Inc.的1.5倍($47.7M vs $31.4M),Ponce Financial Group, Inc.净利率更高(36.3% vs -4.8%,领先41.1%),Ponce Financial Group, Inc.同比增速更快(37.6% vs -47.3%),IRONWOOD PHARMACEUTICALS INC自由现金流更多($74.6M vs $54.6M),过去两年Ponce Financial Group, Inc.的营收复合增速更高(23.7% vs -20.2%)
Ironwood制药公司是一家上市制药企业,其前身为Microbia公司,专注于制药领域相关业务研发与运营,面向市场开发各类创新医药产品,满足未被充分满足的临床医疗需求。
庞塞金融集团是总部位于美国的金融控股公司,核心子公司为庞塞银行,主要服务纽约大都会区的多元文化、移民及中低收入社区,提供存款账户、按揭贷款、小微企业融资、个人信贷等零售及商业银行服务。
IRWD vs PDLB — 直观对比
营收规模更大
IRWD
是对方的1.5倍
$31.4M
营收增速更快
PDLB
高出84.9%
-47.3%
净利率更高
PDLB
高出41.1%
-4.8%
自由现金流更多
IRWD
多$20.0M
$54.6M
两年增速更快
PDLB
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $47.7M | $31.4M |
| 净利润 | $-2.3M | $10.1M |
| 毛利率 | — | — |
| 营业利润率 | 14.3% | 43.6% |
| 净利率 | -4.8% | 36.3% |
| 营收同比 | -47.3% | 37.6% |
| 净利润同比 | -200.9% | 245.6% |
| 每股收益(稀释后) | $0.01 | $0.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
IRWD
PDLB
| Q4 25 | $47.7M | $31.4M | ||
| Q3 25 | $122.1M | $26.7M | ||
| Q2 25 | $85.2M | $26.5M | ||
| Q1 25 | $41.1M | $24.6M | ||
| Q4 24 | $90.5M | $22.8M | ||
| Q3 24 | $91.6M | $20.2M | ||
| Q2 24 | $94.4M | $20.2M | ||
| Q1 24 | $74.9M | $20.5M |
净利润
IRWD
PDLB
| Q4 25 | $-2.3M | $10.1M | ||
| Q3 25 | $40.1M | $6.5M | ||
| Q2 25 | $23.6M | $6.1M | ||
| Q1 25 | $-37.4M | $6.0M | ||
| Q4 24 | $2.3M | $2.9M | ||
| Q3 24 | $3.6M | $2.4M | ||
| Q2 24 | $-860.0K | $3.2M | ||
| Q1 24 | $-4.2M | $2.4M |
营业利润率
IRWD
PDLB
| Q4 25 | 14.3% | 43.6% | ||
| Q3 25 | 61.8% | 32.8% | ||
| Q2 25 | 53.2% | 30.2% | ||
| Q1 25 | -70.7% | 32.5% | ||
| Q4 24 | 34.8% | 19.6% | ||
| Q3 24 | 28.0% | 15.2% | ||
| Q2 24 | 26.5% | 21.8% | ||
| Q1 24 | 14.7% | 18.3% |
净利率
IRWD
PDLB
| Q4 25 | -4.8% | 36.3% | ||
| Q3 25 | 32.8% | 24.3% | ||
| Q2 25 | 27.7% | 23.0% | ||
| Q1 25 | -90.9% | 24.2% | ||
| Q4 24 | 2.5% | 14.1% | ||
| Q3 24 | 4.0% | 12.1% | ||
| Q2 24 | -0.9% | 15.8% | ||
| Q1 24 | -5.6% | 11.8% |
每股收益(稀释后)
IRWD
PDLB
| Q4 25 | $0.01 | $0.43 | ||
| Q3 25 | $0.23 | $0.27 | ||
| Q2 25 | $0.14 | $0.25 | ||
| Q1 25 | $-0.23 | $0.25 | ||
| Q4 24 | $0.03 | $0.11 | ||
| Q3 24 | $0.02 | $0.10 | ||
| Q2 24 | $-0.01 | $0.14 | ||
| Q1 24 | $-0.03 | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $215.5M | $126.2M |
| 总债务越低越好 | — | $596.1M |
| 股东权益账面价值 | $-261.8M | $541.5M |
| 总资产 | $396.9M | $3.2B |
| 负债/权益比越低杠杆越低 | — | 1.10× |
8季度趋势,按日历期对齐
现金及短期投资
IRWD
PDLB
| Q4 25 | $215.5M | $126.2M | ||
| Q3 25 | $140.4M | $146.6M | ||
| Q2 25 | $92.9M | $126.6M | ||
| Q1 25 | $108.5M | $129.9M | ||
| Q4 24 | $88.6M | $139.8M | ||
| Q3 24 | $88.2M | $155.8M | ||
| Q2 24 | $105.5M | $103.2M | ||
| Q1 24 | $121.5M | $134.7M |
总债务
IRWD
PDLB
| Q4 25 | — | $596.1M | ||
| Q3 25 | $199.5M | $521.1M | ||
| Q2 25 | $199.3M | $536.1M | ||
| Q1 25 | $199.2M | $521.1M | ||
| Q4 24 | $199.0M | $596.1M | ||
| Q3 24 | $198.8M | $580.4M | ||
| Q2 24 | $198.6M | $680.4M | ||
| Q1 24 | $398.3M | $680.4M |
股东权益
IRWD
PDLB
| Q4 25 | $-261.8M | $541.5M | ||
| Q3 25 | $-264.2M | $529.8M | ||
| Q2 25 | $-308.2M | $521.1M | ||
| Q1 25 | $-334.1M | $513.9M | ||
| Q4 24 | $-301.3M | $505.5M | ||
| Q3 24 | $-311.3M | $504.6M | ||
| Q2 24 | $-321.7M | $497.7M | ||
| Q1 24 | $-330.5M | $493.7M |
总资产
IRWD
PDLB
| Q4 25 | $396.9M | $3.2B | ||
| Q3 25 | $396.1M | $3.2B | ||
| Q2 25 | $342.9M | $3.2B | ||
| Q1 25 | $327.2M | $3.1B | ||
| Q4 24 | $350.9M | $3.0B | ||
| Q3 24 | $389.5M | $3.0B | ||
| Q2 24 | $395.6M | $2.8B | ||
| Q1 24 | $438.8M | $2.8B |
负债/权益比
IRWD
PDLB
| Q4 25 | — | 1.10× | ||
| Q3 25 | — | 0.98× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.01× | ||
| Q4 24 | — | 1.18× | ||
| Q3 24 | — | 1.15× | ||
| Q2 24 | — | 1.37× | ||
| Q1 24 | — | 1.38× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $74.6M | $55.6M |
| 自由现金流经营现金流 - 资本支出 | $74.6M | $54.6M |
| 自由现金流率自由现金流/营收 | 156.3% | 173.9% |
| 资本支出强度资本支出/营收 | 0.0% | 3.1% |
| 现金转化率经营现金流/净利润 | — | 5.48× |
| 过去12个月自由现金流最近4个季度 | $127.0M | $74.3M |
8季度趋势,按日历期对齐
经营现金流
IRWD
PDLB
| Q4 25 | $74.6M | $55.6M | ||
| Q3 25 | $47.6M | $1.4M | ||
| Q2 25 | $-15.1M | $6.2M | ||
| Q1 25 | $20.0M | $13.1M | ||
| Q4 24 | $15.2M | $7.2M | ||
| Q3 24 | $9.9M | $-14.6M | ||
| Q2 24 | $33.5M | $-2.6M | ||
| Q1 24 | $45.0M | $1.5M |
自由现金流
IRWD
PDLB
| Q4 25 | $74.6M | $54.6M | ||
| Q3 25 | $47.6M | $786.0K | ||
| Q2 25 | $-15.1M | $5.9M | ||
| Q1 25 | $19.9M | $12.9M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | $9.9M | $-15.0M | ||
| Q2 24 | $33.4M | $-2.6M | ||
| Q1 24 | $44.9M | $-315.0K |
自由现金流率
IRWD
PDLB
| Q4 25 | 156.3% | 173.9% | ||
| Q3 25 | 39.0% | 2.9% | ||
| Q2 25 | -17.7% | 22.4% | ||
| Q1 25 | 48.4% | 52.6% | ||
| Q4 24 | — | 19.7% | ||
| Q3 24 | 10.8% | -74.1% | ||
| Q2 24 | 35.4% | -13.0% | ||
| Q1 24 | 60.0% | -1.5% |
资本支出强度
IRWD
PDLB
| Q4 25 | 0.0% | 3.1% | ||
| Q3 25 | 0.0% | 2.3% | ||
| Q2 25 | 0.0% | 1.0% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.0% | 11.9% | ||
| Q3 24 | 0.0% | 2.0% | ||
| Q2 24 | 0.1% | 0.3% | ||
| Q1 24 | 0.1% | 8.7% |
现金转化率
IRWD
PDLB
| Q4 25 | — | 5.48× | ||
| Q3 25 | 1.19× | 0.21× | ||
| Q2 25 | -0.64× | 1.01× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | 6.74× | 2.46× | ||
| Q3 24 | 2.71× | -5.99× | ||
| Q2 24 | — | -0.80× | ||
| Q1 24 | — | 0.61× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图